Highlights Invitae Corporation

Equities

NVTA.Q

US46185L1035

End-of-day quote OTC Markets Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
0.001 ^USD	+100.00%		-67.74%	-99.84%

Apr. 25	Labcorp beats quarterly estimates on strong testing demand	RE
Apr. 25	Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Labcorp beats quarterly estimates on strong testing demand	Apr. 25	RE
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	Apr. 24	RE
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million.	Apr. 23	CI
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation for approximately $240 million.	Apr. 23	CI
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance	Apr. 11	CI
Invitae Launches Update to Invitae Generation: Clinical Variant Modeling Improves Variant Classification	Mar. 12	CI
Earnings Flash (NVTA) INVITAE CORPORATION Posts Q4 Revenue $127.8M	Mar. 06	MT
Invitae Corporation Provides Unaudited Earnings Guidance for the Fourth Quarter and Full Year of 2023	Mar. 06	CI
Invitae gets court approval for five-month bankruptcy sale	Feb. 15	RE
Global markets live: Airbnb, Sony, Uber, Lyft, Nvidia...	Feb. 14
Genetic test maker Invitae files for bankruptcy protection in US	Feb. 13	RE
Invitae Corporation Lists Estimated Assets In The Range Of $500 Mln -$1 Bln - Court Filing	Feb. 13	RE
INVITAE CORPORATION LISTS ESTIMATED LIABILITIES IN THE RANGE OF…	Feb. 13	RE
Genetic test maker Invitae files for voluntary Chapter 11 protection	Feb. 13	RE
Invitae Collaborates With BridgeBio Pharma for Rare Disease Therapeutics	Jan. 30	MT
Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics	Jan. 30	CI
Natera Acquires Reproductive Health Assets From Invitae	Jan. 22	MT
Natera, Inc. completed the acquisition of certain reproductive health assets from Invitae Corporation (NYSE : NVTA) for $52.5 million	Jan. 21	CI
Invitae Sells Certain Assets of YouScript Platform to Aranscia	Nov. 16	MT
Invitae Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Invitae Corporation

Equities

NVTA.Q

US46185L1035

Highlights

Filters